ESC 365 - Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice

ESC Premium Access

Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice

Session: Poster Session 1 - Lipids and metabolism

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Doctor A. Rahadian (Tokushima, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Arief Rahadian

Institute of Health Biosciences- The University of Tokushima Graduate School, Tokushima (Japan)

0 follower

11 more presentations in this session

Atheroprotective effects of 17beta-estradiol are mediated by PPARgamma in human coronary artery smooth muscle cells

Speaker: Doctor J. Jehle (Bonn, DE)

Shear stress induced unfolding of von willebrand factor may be involved in the premature development of myocardial infarction

Speaker: Mr I. Melnikov (Moscow, RU)

A novel CD147 inhibitor SP-8356 attenuates plaque progression and stabilizes vulnerable plaque in ApoE-deficient mice

Speaker: Doctor K. Pahk (Seoul, KR)

Antibody treatment against pathological pancreatic islet amyloid polypeptide (IAPP) aggregates restores endothelial dysfunction in human-IAPP transgenic rats

Speaker: Doctor A. Taheri (Zurich, CH)

Molecular genetics of familial hypercholesterolemia in Israel revisited

Speaker: Doctor R. Durst (Jerusalem, IL)

Access the full session

Poster Session 1 - Lipids and metabolism

Speakers: Doctor A. Rahadian, Doctor J. Jehle, Mr I. Melnikov, Doctor K. Pahk, Doctor A. Taheri...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources